BGM Group Stock Soars 21.83% on AI Integration Push

BGM Group's stock surged by 21.83% in pre-market trading on July 24, 2025, marking a significant rise that has caught the attention of investors and analysts alike.

BGM Group is rapidly advancing its AI-driven vertical integration strategy through strategic acquisitions in biopharma, logistics, and health-focused assets. This move is part of the company's broader transformation from traditional pharmaceuticals to an AI-driven platform, which is expected to enhance its operational efficiency and market competitiveness.

The company is currently in the early stages of validating the performance of its AI platform, with the first fully integrated quarterly earnings report set to be released soon. This report is anticipated to provide further insights into the effectiveness of BGM Group's AI initiatives and their impact on the company's financial performance.